PTC Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
PTC Therapeutics, Inc.‘s stocks are currently a part of 173 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 73.88M shares of PTC Therapeutics, Inc.. Compared to the previous quarter, the number fell by -1.91% or -1.43M shares fewer. As for the holding position changes, 35.26% (61) of current hedge fund investors increased the number of shares held, 31.21% (54) of current holders sold a part of the shares held, and 10.98% (19) closed the holdings completely. 27 hedge funds are new holders of PTC Therapeutics, Inc. stock in Q1 2022, it is 15.61% of total holders.
Hedge funds holding PTC Therapeutics (Q2 2017 – Q1 2022)
| Q2 2017 | 113 |
|---|---|
| Q3 2017 | 128 |
| Q4 2017 | 123 |
| Q1 2018 | 146 |
| Q2 2018 | 165 |
| Q3 2018 | 178 |
| Q4 2018 | 162 |
| Q1 2019 | 172 |
| Q2 2019 | 172 |
| Q3 2019 | 181 |
| Q4 2019 | 205 |
| Q1 2020 | 200 |
| Q2 2020 | 200 |
| Q3 2020 | 192 |
| Q4 2020 | 210 |
| Q1 2021 | 202 |
| Q2 2021 | 177 |
| Q3 2021 | 179 |
| Q4 2021 | 170 |
| Q1 2022 | 173 |
Hedge funds changes in PTC Therapeutics positions (Q2 2017 – Q1 2022)
| Q2 2017 | 20 | 36 | 38 | 18 | 1 |
|---|---|---|---|---|---|
| Q3 2017 | 29 | 52 | 32 | 13 | 2 |
| Q4 2017 | 24 | 42 | 40 | 27 | -10 |
| Q1 2018 | 42 | 40 | 44 | 18 | 2 |
| Q2 2018 | 48 | 56 | 41 | 27 | -7 |
| Q3 2018 | 42 | 50 | 60 | 28 | -2 |
| Q4 2018 | 19 | 70 | 48 | 35 | -10 |
| Q1 2019 | 31 | 77 | 36 | 21 | 7 |
| Q2 2019 | 28 | 62 | 57 | 26 | -1 |
| Q3 2019 | 35 | 70 | 54 | 26 | -4 |
| Q4 2019 | 58 | 66 | 59 | 32 | -10 |
| Q1 2020 | 30 | 80 | 69 | 32 | -11 |
| Q2 2020 | 29 | 88 | 56 | 27 | 0 |
| Q3 2020 | 21 | 67 | 73 | 29 | 2 |
| Q4 2020 | 40 | 64 | 81 | 21 | 4 |
| Q1 2021 | 27 | 73 | 81 | 32 | -11 |
| Q2 2021 | 17 | 81 | 49 | 40 | -10 |
| Q3 2021 | 22 | 67 | 53 | 18 | 19 |
| Q4 2021 | 21 | 55 | 61 | 30 | 3 |
| Q1 2022 | 27 | 61 | 54 | 19 | 12 |
Hedge funds changes in PTC Therapeutics stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 19,116,000 | 9,924,000 |
|---|---|---|
| Q3 2017 | 41,176,312 | 86,067,000 |
| Q4 2017 | 9,168,000 | 48,018,000 |
| Q1 2018 | 24,269,000 | 27,077,000 |
| Q2 2018 | 24,856,000 | 23,886,000 |
| Q3 2018 | 22,295,000 | 31,933,000 |
| Q4 2018 | 11,883,000 | 15,768,000 |
| Q1 2019 | 10,042,000 | 8,991,000 |
| Q2 2019 | 19,221,000 | 14,195,000 |
| Q3 2019 | 39,309,000 | 28,368,000 |
| Q4 2019 | 53,623,000 | 44,425,000 |
| Q1 2020 | 56,165,000 | 15,300,000 |
| Q2 2020 | 34,566,000 | 81,014,546,000 |
| Q3 2020 | 15,556,000 | 10,170,000 |
| Q4 2020 | 10,887,000 | 256,000 |
| Q1 2021 | 12,277,000 | 894,000 |
| Q2 2021 | 11,839,000 | 5,245,000 |
| Q3 2021 | 4,885,000 | 4,602,000 |
| Q4 2021 | 1,856,000 | 2,028,000 |
| Q1 2022 | 1,991,000 | 1,276,000 |